Allspring Global Investments
BPMC

Allspring Global Investments’s Blueprint Medicines BPMC Stock Holding History

Allspring Global Investments’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,687
Closed -$602K – 1642
2025
Q2 		$602K Sell
4,687
-270
-5% -$28K ﹤0.01% 1292
2025
Q1 		$426K Buy
4,957
+1,735
+54% +$169K ﹤0.01% 1491
2024
Q4 		$281K Buy
3,222
+16
+0.5% +$1.47K ﹤0.01% 1605
2024
Q3 		$297K Buy
3,206
+927
+41% +$92.1K ﹤0.01% 1598
2024
Q2 		$246K Sell
2,279
-24
-1% -$2.4K ﹤0.01% 1669
2024
Q1 		$218K Buy
+2,303
New +$198K ﹤0.01% 1688
2023
Q4 		– Sell
-3,137
Closed -$158K – 2282
2023
Q3 		$158K Buy
3,137
+653
+26% +$34.9K ﹤0.01% 1832
2023
Q2 		$157K Sell
2,484
-227
-8% -$12.3K ﹤0.01% 1889
2023
Q1 		$122K Buy
2,711
+51
+2% +$2.3K ﹤0.01% 1978
2022
Q4 		$117K Sell
2,660
-59
-2% -$2.83K ﹤0.01% 2017
2022
Q3 		$179K Buy
2,719
+434
+19% +$27.9K ﹤0.01% 1856
2022
Q2 		$115K Sell
2,285
-23,210
-91% -$1.36M ﹤0.01% 2008
2022
Q1 		$1.63M Sell
25,495
-6,576
-21% -$472K ﹤0.01% 1614
2021
Q4 		$3.44M Buy
+32,071
New +$3.35M ﹤0.01% 1311

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Allspring Global Investments's BPMC Position: Q3 2025 in Review

Allspring Global Investments sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 4,687 shares — an estimated $602K sold.

Allspring Global Investments first reported a position in BPMC in Q4 2021 and held it in 14 quarters. The position peaked at $3.44M in Q4 2021. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Allspring Global Investments reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Allspring Global Investments sold 4,687 Blueprint Medicines shares in Q3 2025, an estimated $602K.
  • Allspring Global Investments first reported a position in Blueprint Medicines in Q4 2021 and held it in 14 quarters.
  • Allspring Global Investments's Blueprint Medicines position peaked at $3.44M in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Allspring Global Investments's 13F filing for Q3 2025, filed 20 Oct 2025.